Nellie Lew, Ph.D. Email & Phone Number

Washington, District Of Columbia, United States

Washington, District Of Columbia

Silver Spring, Maryland

Silver Spring, Md

•Supervise and manage team of economists responsible for conducting prospective and retrospective cost-benefit analyses of FDA regulations, proposed legislation, and other agency-initiated activities•Represent the agency on economic issues before OMB, HHS, and select non-governmental organizations•Assign, direct, plan, and coordinate economic analyses to evaluate and assess FDA policies and activities •Lead economics training, and provide economics support to operating units of FDA•Plan and coordinate the allocation of operating and contract funds for the Economics Staff

•Supervised and managed economic analyses in support of Agency decision-making resulting in the establishment of new regulations, policies, and program objectives•Represented the Economics Staff in Agency leadership meetings and negotiations•Provided strategic advice on budget and personnel actions

•Conducted economic analyses, including cost-benefit, cost-effectiveness, and retrospective analyses, of agency regulations and policies in accordance with Executive Order No. 12866, Executive Order No. 13563, OMB’s Circular A-4, the Regulatory Flexibility Act, and the Unfunded Mandates Reform Act of 1995•Authored regulatory impact analyses across product areas, including pharmaceutical drugs, medical devices, food safety, and nutrition• Performed statistical and risk analyses to evaluate the impact and performance of agency programs and policies•Presented findings of economic studies to technical and non-technical audiences; conducted briefings for senior agency leadership and policy officials•Assisted with reviewing analyses performed by junior economists

•Led economic studies on affected industries and markets that involve the collection, statistical manipulation, and analysis of data from internal and external sources•Served as technical economics representative on intra- and inter-agency working groups, including the working group to support the re-authorization of the Medical Device User Fee Act and the Prescription Drug User Fee Act; and the HHS-wide working group to coordinate economic methods and to develop department-wide guidance on regulatory impact analyses •Developed and managed key measures to improve organizational performance related to strategic goals and to enhance internal processes and planning efforts

•Reviewed guidance documents, press releases, testimony, and legislative proposals to ensure accuracy and consistency with HHS policies•Provided analytical support and economic advice to senior policy officials on major policy initiatives•Served on the HHS-wide analytics team of economists and analysts to review existing practices, to establish protocols for review of regulations on an ongoing basis, to identify best practices, and to promote consistent approaches to analysis•Developed research proposals for inter-agency collaboration in support of policy initiatives

•Led discussion sections for courses in Principles of Microeconomics, Principles of Macroeconomics, Intermediate Microeconomics, Intermediate Macroeconomics, and Introductory Statistics•Graded homework and other course assignments•Created, administered, and graded quizzes and exams•Held office hours and review sessions•Led computer lab tutorials on Excel and statistical software, such as E-Views

Doctor Of Philosophy - Phd, Economics

John F. Kennedy School Of Government, Senior Executive Fellow

Master Of Arts - Ma, Economics

Bachelor Of Arts - Ba, International Studies